Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Gillespie

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Postgraduate Medicine|January 31, 2017
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptomsSharon J Parish, John A Gillespie
International Journal of Nanomedicine|September 24, 2009
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspensionBenoit Deschamps, Naomi Musaji, John A Gillespie
Journal of Affective Disorders|March 23, 2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorderTeri Pearlstein, Kimberly A Yonkers, Rana Fayyad, et al.
Journal of Affective Disorders|March 23, 2005
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phaseKimberly A Yonkers, Teri Pearlstein, Rana Fayyad, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 10, 2014
Impact of changing U.S. demographics on the decline in smoking prevalence, 1980-2010Jamie Tam, Kenneth E Warner, Brenda W Gillespie, et al.
International Clinical Psychopharmacology|June 21, 2003
Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studiesAlan D Feiger, Martine F Flament, Patrice Boyer, et al.
The Journal of Clinical Psychiatry|November 17, 2006
Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategiesSusan G Kornstein, Teri B Pearlstein, Rana Fayyad, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?Joseph A Caruana, Marc N McCabe, Audrey D Smith, et al.
Journal of Medical Economics|August 20, 2021
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF modelMatthew Sussman, Manuela Di Fusco, Charles Y Tao, et al.
Current Medical Research and Opinion|October 11, 2021
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic reviewMatthew Sussman, Geoffrey D Barnes, Jennifer D Guo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Postgraduate Medicine|January 31, 2017
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptomsSharon J Parish, John A Gillespie
International Journal of Nanomedicine|September 24, 2009
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspensionBenoit Deschamps, Naomi Musaji, John A Gillespie
Journal of Affective Disorders|March 23, 2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorderTeri Pearlstein, Kimberly A Yonkers, Rana Fayyad, et al.
Journal of Affective Disorders|March 23, 2005
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phaseKimberly A Yonkers, Teri Pearlstein, Rana Fayyad, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 10, 2014
Impact of changing U.S. demographics on the decline in smoking prevalence, 1980-2010Jamie Tam, Kenneth E Warner, Brenda W Gillespie, et al.
International Clinical Psychopharmacology|June 21, 2003
Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studiesAlan D Feiger, Martine F Flament, Patrice Boyer, et al.
The Journal of Clinical Psychiatry|November 17, 2006
Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategiesSusan G Kornstein, Teri B Pearlstein, Rana Fayyad, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?Joseph A Caruana, Marc N McCabe, Audrey D Smith, et al.
Journal of Medical Economics|August 20, 2021
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF modelMatthew Sussman, Manuela Di Fusco, Charles Y Tao, et al.
Current Medical Research and Opinion|October 11, 2021
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic reviewMatthew Sussman, Geoffrey D Barnes, Jennifer D Guo, et al.
Pageof 2